ESR1 and breast neoplasm: Simlarly, a regSNV in the promoter of GSTM1 gene, rs36208869, was predicted in our pipeline to increase ER binding and was shown to be highly correlated with the expression of GSTM1 whose higher levels in ER+ breast tumors are associated with a better survival.